Submit Manuscript

Most Accessed Articles

Need to Think Outside Organ-based Diagnosis to Molecular Diagnostics

Author(s):Alia Albawardi

[Volume:1 Issue:1]
Pages: 10-12 (3)
Clinical Research in India - Current Scenario and the Need of the Hour

Author(s):Meenakshi Kafaltia and Mukul Manchanda

[Volume:2 Issue:1]
Pages: 37-45 (9)
Overview of Periodic Safety Update Reports: Where Have We Reached?

Author(s):Ruchika Sharma, Kamal Kant and Anoop Kumar*

[Volume:7 Issue:1]
Pages: 4-11 (8)
Regulatory Aspects of Post-Approval Safety Reporting for Generic Drug Products in the US

Author(s):Priti J. Mehta and Chandni K. Doshi

[Volume:3 Issue:3]
Pages: 142-150 (9)
Pharmacokinetics-Guided Dosing of 5-Fluorouracil for Precision Cancer Treatment: A Focus on Colorectal Carcinoma

Author(s):Yanming Chen and Nelson S. Yee

[Volume:3 Issue:3]
Pages: 159-163 (5)
Comparison of Regulatory Requirements for Filing Drug Master File (DMF) in Emerging Markets - China, Brazil & South Korea

Author(s):Kunta N. Reddy and Surenahalli G. Vasantharaju*

[Volume:7 Issue:1]
Pages: 71-81 (11)
Comparative Account of Quality Management and Regulatory Aspects of Products with Health Claims: Existing Approaches and Future Challenges for Probiotics and Herbal Products

Author(s):Malika Arora and Ashish Baldi

[Volume:2 Issue:3]
Pages: 123-132 (10)
Post-Approval Changes in Pharmaceuticals: Regulatory Perspectives in Europe

Author(s):Pankaj Kumar, Vibhu Yadav and Deepak Kaushik

[Volume:2 Issue:2]
Pages: 60-68 (9)
Biosimilars Regulation in the United States and FDA Approved Biosimilars from 2015-2018

Author(s): Vikram, Aakash Deep*, Manita, Avtar C. Rana, Monu Yadav and Rakesh K. Marwaha

[Volume:7 Issue:1]
Pages: 12-29 (18)